Pemetrexed induces both intrinsic and extrinsic apoptosis through ataxia telangiectasia mutated/p53-dependent and -independent signaling pathways

Tsung Ying Yang, Gee Chen Chang, Kun Chieh Chen, Hsiao Wen Hung, Kuo Hsuan Hsu, Chi Hao Wu, Gwo Tarng Sheu, Shih Lan Hsu

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Pemetrexed, a new-generation antifolate, has demonstrated promising single-agent activity in front- and second-line treatments of non-small cell lung cancer. However, the molecular mechanism of pemetrexed-mediated antitumor activity remains unclear. The current study shows that pemetrexed induced DNA damage and caspase-2, -3, -8, and -9 activation in A549 cells and that treatment with caspase inhibitors significantly abolished cell death, suggesting a caspase-dependent apoptotic mechanism. The molecular events of pemetrexed-mediated apoptosis was associated with the activation of ataxia telangiectasia mutated (ATM)/p53-dependent and -independent signaling pathways, which promoted intrinsic and extrinsic apoptosis by upregulating Bax, PUMA, Fas, DR4, and DR5 and activating the caspase signaling cascade. Supplementation with dTTP allowed normal S-phase progression and rescued apoptotic death in response to pemetrexed. Overall, our findings reveal that the decrease of thymidylate synthase and the increase of Bax, PUMA, Fas, DR4, and DR5 genes may serve as biomarkers for predicting responsiveness to pemetrexed.

Original languageEnglish
Pages (from-to)183-194
Number of pages12
JournalMolecular Carcinogenesis
Volume52
Issue number3
DOIs
Publication statusPublished - Mar 1 2013
Externally publishedYes

Fingerprint

Pemetrexed
Ataxia Telangiectasia
Apoptosis
Caspases
Caspase 2
Folic Acid Antagonists
Thymidylate Synthase
Caspase Inhibitors
S Phase
Non-Small Cell Lung Carcinoma
Caspase 3
DNA Damage
Cell Death
Biomarkers

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pemetrexed induces both intrinsic and extrinsic apoptosis through ataxia telangiectasia mutated/p53-dependent and -independent signaling pathways. / Yang, Tsung Ying; Chang, Gee Chen; Chen, Kun Chieh; Hung, Hsiao Wen; Hsu, Kuo Hsuan; Wu, Chi Hao; Sheu, Gwo Tarng; Hsu, Shih Lan.

In: Molecular Carcinogenesis, Vol. 52, No. 3, 01.03.2013, p. 183-194.

Research output: Contribution to journalArticle

Yang, Tsung Ying ; Chang, Gee Chen ; Chen, Kun Chieh ; Hung, Hsiao Wen ; Hsu, Kuo Hsuan ; Wu, Chi Hao ; Sheu, Gwo Tarng ; Hsu, Shih Lan. / Pemetrexed induces both intrinsic and extrinsic apoptosis through ataxia telangiectasia mutated/p53-dependent and -independent signaling pathways. In: Molecular Carcinogenesis. 2013 ; Vol. 52, No. 3. pp. 183-194.
@article{6e5f2a003d514cc0b8855d4a5e1b0b81,
title = "Pemetrexed induces both intrinsic and extrinsic apoptosis through ataxia telangiectasia mutated/p53-dependent and -independent signaling pathways",
abstract = "Pemetrexed, a new-generation antifolate, has demonstrated promising single-agent activity in front- and second-line treatments of non-small cell lung cancer. However, the molecular mechanism of pemetrexed-mediated antitumor activity remains unclear. The current study shows that pemetrexed induced DNA damage and caspase-2, -3, -8, and -9 activation in A549 cells and that treatment with caspase inhibitors significantly abolished cell death, suggesting a caspase-dependent apoptotic mechanism. The molecular events of pemetrexed-mediated apoptosis was associated with the activation of ataxia telangiectasia mutated (ATM)/p53-dependent and -independent signaling pathways, which promoted intrinsic and extrinsic apoptosis by upregulating Bax, PUMA, Fas, DR4, and DR5 and activating the caspase signaling cascade. Supplementation with dTTP allowed normal S-phase progression and rescued apoptotic death in response to pemetrexed. Overall, our findings reveal that the decrease of thymidylate synthase and the increase of Bax, PUMA, Fas, DR4, and DR5 genes may serve as biomarkers for predicting responsiveness to pemetrexed.",
author = "Yang, {Tsung Ying} and Chang, {Gee Chen} and Chen, {Kun Chieh} and Hung, {Hsiao Wen} and Hsu, {Kuo Hsuan} and Wu, {Chi Hao} and Sheu, {Gwo Tarng} and Hsu, {Shih Lan}",
year = "2013",
month = "3",
day = "1",
doi = "10.1002/mc.21842",
language = "English",
volume = "52",
pages = "183--194",
journal = "Molecular Carcinogenesis",
issn = "0899-1987",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Pemetrexed induces both intrinsic and extrinsic apoptosis through ataxia telangiectasia mutated/p53-dependent and -independent signaling pathways

AU - Yang, Tsung Ying

AU - Chang, Gee Chen

AU - Chen, Kun Chieh

AU - Hung, Hsiao Wen

AU - Hsu, Kuo Hsuan

AU - Wu, Chi Hao

AU - Sheu, Gwo Tarng

AU - Hsu, Shih Lan

PY - 2013/3/1

Y1 - 2013/3/1

N2 - Pemetrexed, a new-generation antifolate, has demonstrated promising single-agent activity in front- and second-line treatments of non-small cell lung cancer. However, the molecular mechanism of pemetrexed-mediated antitumor activity remains unclear. The current study shows that pemetrexed induced DNA damage and caspase-2, -3, -8, and -9 activation in A549 cells and that treatment with caspase inhibitors significantly abolished cell death, suggesting a caspase-dependent apoptotic mechanism. The molecular events of pemetrexed-mediated apoptosis was associated with the activation of ataxia telangiectasia mutated (ATM)/p53-dependent and -independent signaling pathways, which promoted intrinsic and extrinsic apoptosis by upregulating Bax, PUMA, Fas, DR4, and DR5 and activating the caspase signaling cascade. Supplementation with dTTP allowed normal S-phase progression and rescued apoptotic death in response to pemetrexed. Overall, our findings reveal that the decrease of thymidylate synthase and the increase of Bax, PUMA, Fas, DR4, and DR5 genes may serve as biomarkers for predicting responsiveness to pemetrexed.

AB - Pemetrexed, a new-generation antifolate, has demonstrated promising single-agent activity in front- and second-line treatments of non-small cell lung cancer. However, the molecular mechanism of pemetrexed-mediated antitumor activity remains unclear. The current study shows that pemetrexed induced DNA damage and caspase-2, -3, -8, and -9 activation in A549 cells and that treatment with caspase inhibitors significantly abolished cell death, suggesting a caspase-dependent apoptotic mechanism. The molecular events of pemetrexed-mediated apoptosis was associated with the activation of ataxia telangiectasia mutated (ATM)/p53-dependent and -independent signaling pathways, which promoted intrinsic and extrinsic apoptosis by upregulating Bax, PUMA, Fas, DR4, and DR5 and activating the caspase signaling cascade. Supplementation with dTTP allowed normal S-phase progression and rescued apoptotic death in response to pemetrexed. Overall, our findings reveal that the decrease of thymidylate synthase and the increase of Bax, PUMA, Fas, DR4, and DR5 genes may serve as biomarkers for predicting responsiveness to pemetrexed.

UR - http://www.scopus.com/inward/record.url?scp=84880097249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880097249&partnerID=8YFLogxK

U2 - 10.1002/mc.21842

DO - 10.1002/mc.21842

M3 - Article

C2 - 22086658

AN - SCOPUS:84880097249

VL - 52

SP - 183

EP - 194

JO - Molecular Carcinogenesis

JF - Molecular Carcinogenesis

SN - 0899-1987

IS - 3

ER -